| 1 |
Hegemann JD, Süssmuth RD. Matters of class: coming of age of class III and IV lanthipeptides. RSC Chem Biol 2020;1:110-27. [PMID: 34458752 DOI: 10.1039/d0cb00073f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 2 |
Oeyen M, Meyen E, Doijen J, Schols D, Delgui LR. In-Depth Characterization of Zika Virus Inhibitors Using Cell-Based Electrical Impedance. Microbiol Spectr. [DOI: 10.1128/spectrum.00491-22] [Reference Citation Analysis]
|
| 3 |
Fong YD, Chu JJH. Natural products as Zika antivirals. Med Res Rev 2022. [PMID: 35593443 DOI: 10.1002/med.21891] [Reference Citation Analysis]
|
| 4 |
Tocchetti A, Iorio M, Hamid Z, Armirotti A, Reggiani A, Donadio S. Understanding the Mechanism of Action of NAI-112, a Lanthipeptide with Potent Antinociceptive Activity. Molecules 2021;26:6764. [PMID: 34833857 DOI: 10.3390/molecules26226764] [Reference Citation Analysis]
|
| 5 |
Wichit S, Gumpangseth N, Hamel R, Yainoy S, Arikit S, Punsawad C, Missé D. Chikungunya and Zika Viruses: Co-Circulation and the Interplay between Viral Proteins and Host Factors. Pathogens 2021;10:448. [PMID: 33918691 DOI: 10.3390/pathogens10040448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Marrazzo P, Cricca M, Nastasi C. Are the Organoid Models an Invaluable Contribution to ZIKA Virus Research? Pathogens 2021;10:1233. [PMID: 34684182 DOI: 10.3390/pathogens10101233] [Reference Citation Analysis]
|
| 7 |
González-Pérez CJ, Aispuro-Hernández E, Vargas-Arispuro I, Hernández-Mendoza A, Ayala Zavala JF, Martínez-Téllez MA. Are Bacteriocins a Feasible Solution for Current Diverse Global Problems? Protein Pept Lett 2021. [PMID: 34629038 DOI: 10.2174/0929866528666211008154430] [Reference Citation Analysis]
|
| 8 |
Wiebach V, Mainz A, Schnegotzki R, Siegert MJ, Hügelland M, Pliszka N, Süssmuth RD. An Amphipathic Alpha-Helix Guides Maturation of the Ribosomally-Synthesized Lipolanthines. Angew Chem Int Ed Engl 2020;59:16777-85. [PMID: 32533616 DOI: 10.1002/anie.202003804] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 9 |
Pandey M, Bhati A, Priya K, Sharma KK, Singhal B. Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications. Probiotics Antimicrob Proteins 2021. [PMID: 34806151 DOI: 10.1007/s12602-021-09875-4] [Reference Citation Analysis]
|
| 10 |
Yoon BK, Jeon WY, Sut TN, Cho NJ, Jackman JA. Stopping Membrane-Enveloped Viruses with Nanotechnology Strategies: Toward Antiviral Drug Development and Pandemic Preparedness. ACS Nano 2021;15:125-48. [PMID: 33306354 DOI: 10.1021/acsnano.0c07489] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 11 |
Saiz JC, Martín-Acebes MA, Blázquez AB, Escribano-Romero E, Poderoso T, Jiménez de Oya N. Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation. Virulence 2021;12:1145-73. [PMID: 33843445 DOI: 10.1080/21505594.2021.1908740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
van Staden ADP, van Zyl WF, Trindade M, Dicks LMT, Smith C. Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings. Appl Environ Microbiol 2021;87:e0018621. [PMID: 33962984 DOI: 10.1128/AEM.00186-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Li C, Alam K, Zhao Y, Hao J, Yang Q, Zhang Y, Li R, Li A. Mining and Biosynthesis of Bioactive Lanthipeptides From Microorganisms. Front Bioeng Biotechnol 2021;9:692466. [PMID: 34395400 DOI: 10.3389/fbioe.2021.692466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
